Nisa Investment Advisors
CORT icon

Nisa Investment Advisors’s Corcept Therapeutics CORT Stock Holding History

Nisa Investment Advisors’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$623K Sell
15,446
-5,075
-25% -$190K ﹤0.01% 902
2025
Q4 		$714K Buy
20,521
+2,877
+16% +$226K ﹤0.01% 915
2025
Q3 		$1.47M Buy
17,644
+7,693
+77% +$557K 0.01% 726
2025
Q2 		$730K Buy
9,951
+180
+2% +$13.1K ﹤0.01% 898
2025
Q1 		$1.12M Sell
9,771
-894
-8% -$54.4K 0.01% 793
2024
Q4 		$537K Buy
10,665
+814
+8% +$42.7K ﹤0.01% 1044
2024
Q3 		$456K Buy
9,851
+4,483
+84% +$159K ﹤0.01% 1068
2024
Q2 		$174K Buy
5,368
+510
+10% +$14K ﹤0.01% 1340
2024
Q1 		$122K Sell
4,858
-1,042
-18% -$24.6K ﹤0.01% 1415
2023
Q4 		$192K Buy
5,900
+500
+9% +$13.7K ﹤0.01% 1285
2023
Q3 		$147K Hold
5,400
– – ﹤0.01% 1392
2023
Q2 		$120K Buy
5,400
+20
+0.4% +$460 ﹤0.01% 1465
2023
Q1 		$117K Sell
5,380
-3,230
-38% -$70.8K ﹤0.01% 1461
2022
Q4 		$175K Buy
8,610
+11
+0.1% +$276 ﹤0.01% 1395
2022
Q3 		$233K Buy
8,599
+59
+0.7% +$1.58K ﹤0.01% 1238
2022
Q2 		$203K Hold
8,540
– – ﹤0.01% 1304
2022
Q1 		$192K Sell
8,540
-9,333
-52% -$199K ﹤0.01% 1390
2021
Q4 		$335K Buy
17,873
+2,602
+17% +$52.8K ﹤0.01% 1127
2021
Q3 		$301 Buy
15,271
+10,581
+226% +$221K ﹤0.01% 1275
2021
Q2 		$103 Hold
4,690
– – ﹤0.01% 1678
2021
Q1 		$112 Hold
4,690
– – ﹤0.01% 1703
2020
Q4 		$123K Sell
4,690
-10,833
-70% -$228K ﹤0.01% 1654
2020
Q3 		$270K Sell
15,523
-22,543
-59% -$359K ﹤0.01% 1222
2020
Q2 		$640K Buy
38,066
+22,791
+149% +$320K 0.01% 930
2020
Q1 		$182K Hold
15,275
– – ﹤0.01% 1215
2019
Q4 		$185K Buy
15,275
+3,005
+24% +$41.8K ﹤0.01% 1336
2019
Q3 		$173K Buy
12,270
+11,700
+2,053% +$144K ﹤0.01% 1358
2019
Q2 		$6K Hold
570
– – ﹤0.01% 1857
2019
Q1 		$7K Sell
570
-600
-51% -$7.46K ﹤0.01% 1848
2018
Q4 		$16K Hold
1,170
– – ﹤0.01% 1544
2018
Q3 		$16K Buy
1,170
+20
+2% +$279 ﹤0.01% 1586
2018
Q2 		$18K Buy
1,150
+700
+156% +$12.2K ﹤0.01% 1555
2018
Q1 		$7K Sell
450
-550
-55% -$10.2K ﹤0.01% 1735
2017
Q4 		$18K Hold
1,000
– – ﹤0.01% 1570
2017
Q3 		$19K Hold
1,000
– – ﹤0.01% 1539
2017
Q2 		$12K Buy
1,000
+600
+150% +$6.52K ﹤0.01% 1653
2017
Q1 		$4K Sell
400
-2,600
-87% -$22.8K ﹤0.01% 1822
2016
Q4 		$22K Hold
3,000
– – ﹤0.01% 1604
2016
Q3 		$20K Hold
3,000
– – ﹤0.01% 1647
2016
Q2 		$16K Buy
+3,000
New +$15.6K ﹤0.01% 1689

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Nisa Investment Advisors's CORT Position: Q1 2026 in Review

Nisa Investment Advisors reduced its Corcept Therapeutics (CORT) stake by 25% in Q1 2026, selling an estimated $190K and leaving 15,446 shares worth $623K. The position accounts for ﹤0.01% of the portfolio, ranked #902.

Nisa Investment Advisors first reported a position in CORT in Q2 2016 and has held it in 40 quarters since. The position peaked at $1.47M in Q3 2025. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

  • Nisa Investment Advisors held 15,446 shares of Corcept Therapeutics worth $623K as of Q1 2026.
  • Nisa Investment Advisors sold 5,075 Corcept Therapeutics shares in Q1 2026, an estimated $190K.
  • Corcept Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #902 holding.
  • Nisa Investment Advisors first reported a position in Corcept Therapeutics in Q2 2016 and has held it in 40 quarters since.
  • Nisa Investment Advisors's Corcept Therapeutics position peaked at $1.47M in Q3 2025.
  • 351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.